Craig Barrow, MD
Foot and Ankle Surgery · Spokane, WANPI 1265539944
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $802 of the $995 with a category attached, or 80.6%. Stryker accounts for 64.5% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $368 and has fallen 62.1% since, to $139 in 2025. That places this record below the midpoint for foot and ankle surgery clinicians in WA, where the typical reported total is $1,834.
Across 28 payments — averaging $35.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$642
- Smith+Nephew$178
- Merck$34
- Sawtooth Surgical Solutions Inc$33
- Johnson & Johnson$24
- Polynovo North America LLC$24
- plus $60 from 3 others
What the payments were for
- Food & beverage$80281%
- Gifts$19319%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 15 | $642 |
| Smith+Nephew | 4 | $178 |
| Merck | 2 | $34 |
| Sawtooth Surgical Solutions Inc | 2 | $33 |
| Johnson & Johnson | 1 | $24 |
| Polynovo North America LLC | 1 | $24 |
| Avanos Medical | 1 | $21 |
| Bioventus LLC | 1 | $20 |
| Summit Surgical Corp. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EASYFUSE$118
How this compares
$995 in reported general payments places this provider in the 40th percentile of 203 foot and ankle surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 72 | $1,202 |
| Oxycodone Hcl | 103 | $751 |
| Tizanidine Hcl | 147 | $620 |
| Hydroxyzine Hcl | 67 | $565 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 49 | $526 |
| Cephalexin | 24 | $404 |
| Gabapentin | 19 | $213 |
| Clindamycin Hcl | 14 | $210 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 37 | $202 |
| Hydromorphone Hcl | 15 | $92 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Spokane
- Kevin DowSpokane$20K
- Jessica KohringSpokane$7K
- Brady StewartSpokane$7K
- Kimberly SkallaSpokane$5K
- Jeffrey ChristensenEverett$828K
- David DalstromSeattle$491K
- Richard LamourOlympia$87K
- Adam AlbabaSeattle$46K
- Stephen BenirschkeSeattle$45K
- Craig CliffordFederal Way$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.